Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Moore

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Melanoma Research|October 28, 2017
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600ESigrun Hallmeyer, Rene Gonzalez, David H Lawson, et al.
Liver Research|December 13, 2021
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Natural Product Communications|July 26, 2021
<i>Oroxylum indicum</i> extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Melanoma Research|October 28, 2017
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600ESigrun Hallmeyer, Rene Gonzalez, David H Lawson, et al.
Liver Research|December 13, 2021
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Natural Product Communications|July 26, 2021
<i>Oroxylum indicum</i> extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Pageof 8